John Hayslip
1Patents
0h-index
3Co-inventors
19Inventor score
Filing activity: Nov 4, 2020 → Nov 4, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11285159B2 | Dosing regimens for use in treating myelofibrosis and MPN-related disorders with navitoclax | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.